Jazz Inks Deal with Codiak to Develop Exosome Therapeutics
Jazz Pharmaceuticals plc JAZZ entered into a collaboration with Codiak BioSciences, Inc. to focus on the research, development and commercialization of exosome therapeutics to treat cancer. Jazz gained exclusive worldwide rights to develop, manufacture and commercialize exosome candidates directed at five oncogene targets for hematological malignancies and solid tumors to be developed using Codiak's engEx precision engineering platform for exosome therapeutics […]